Clinical Center; Notice of Closed Meeting, 11660-11661 [2013-03643]
Download as PDF
<![CDATA[
11660
Federal Register / Vol. 78, No. 33 / Tuesday, February 19, 2013 / Notices
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Yvonne Bennett, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5199, MSC 7846, Bethesda, MD
20892, 301–379–3793, bennetty@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 12, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2013–03638 Filed 2–15–13; 8:45 am]
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Dated: February 12, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institute of Biomedical
Imaging And Bioengineering; Notice of
Closed Meeting
[FR Doc. 2013–03642 Filed 2–15–13; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute Of Child Health & Human
Development; Notice of Closed
Meeting
TKELLEY on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel;‘‘Vulvodynia.’’
Date: March 6, 2013.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Express, 1775 Rockville
Pike, Rockville, MD 20852.
Contact Person: Dennis E. Leszczynski,
Ph.D., Scientific Review Officer, Division of
Scientific Review, National Institute of Child
Health, and Human Development, NIH, 6100
Executive Blvd., Room 5B01, Bethesda, MD
20892, 301–435–2717, leszcyd@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
VerDate Mar<15>2010
17:49 Feb 15, 2013
Jkt 229001
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; NIH–NIBIB LRP
Review Meeting (2013–08)
Date: April 5, 2013.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: John K. Hayes, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Boulevard, Room 959, Bethesda,
MD 20892, 301–451–3398,
hayesj@mail.nih.gov.
Dated: February 12, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–03639 Filed 2–15–13; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Heart Placental Axis
Development and Prevention of
Cardiovascular Birth Defects.
Date: March 12, 2013.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5B01,
6100 Executive Boulevard, Rockville, MD
20852 (Telephone Conference Call).
Contact Person: Peter Zelazowski, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892,
301–435–6902, peter.zelazowski@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: February 12, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–03637 Filed 2–15–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Clinical Center; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
Frm 00039
Fmt 4703
Sfmt 4703
E:\FR\FM\19FEN1.SGM
19FEN1
Federal Register / Vol. 78, No. 33 / Tuesday, February 19, 2013 / Notices
hereby given of a meeting of the Board
of Scientific Counselors of the NIH
Clinical Center.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
CLINICAL CENTER, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors of the NIH Clinical Center.
Date: March 4–5, 2013.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate the
Department of Laboratory Medicine.
Place: National Institutes of Health,
Building 10, 10 Center Drive, Room 4–2551,
Bethesda, MD 20892.
Contact Person: David K. Henderson, MD,
Deputy Director for Clinical Care, Office of
the Director, Clinical Center, National
Institutes of Health, Building 10, Room 6–
1480, Bethesda, MD 20892, (301) 496–3515.
Dated: February 12, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–03643 Filed 2–15–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Information: Main Study
Design for the National Children’s
Study
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The Eunice Kennedy Shriver
National Institute for Child Health and
Human Development (NICHD), National
Institutes of Health (NIH), is issuing a
Request for Information (RFI) as part of
the National Children’s Study’s (NCS)
effort to engage communities and
receive public input on specific design
questions for incorporation into the
Main Study Design of the NCS. The
information obtained from RFI
responses will be used to guide the
construction of decision points or
parameters for the Main Study design
TKELLEY on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:49 Feb 15, 2013
Jkt 229001
over the next 12–18 months. This RFI
was preceded by a workshop with the
National Academy of Sciences which
posed similar questions. For background
information on this workshop, please
visit: https://www.nationalchildrens
study.gov/research/workshops/Pages/
nationalacademyofsciences
workshop.aspx.
RFI Release Date is February 11,
2013. Response Close Date is February
25, 2013.
ADDRESSES: To respond by February 25,
2013, please submit comments via email
to NCS_RFI@mail.nih.gov. Please
include citations for any references or
reports that can be used as source
material.
DATES:
FOR FURTHER INFORMATION CONTACT:
Questions about this request for
information may be directed to Kate
Winseck, MSW, The National Children’s
Study, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of
Health, 6100 Executive Blvd., Rm. 5C01,
Bethesda, MD 20891,
NCS_RFI@mail.nih.gov, 301–594–9147.
SUPPLEMENTARY INFORMATION: The
National Children’s Study is a
congressionally mandated longitudinal
birth cohort study intended to examine
the effects of environmental exposures
on the growth, development, and wellbeing of children. The NCS was
mandated by the Children’s Health Act
of 2000 (Pub. L. 106–310). The Study
consists of several components,
including: a pilot or Vanguard Study, a
Main Study focused on exposureresponse relationships, substudies
embedded in the Vanguard Study or the
Main Study, and formative research
projects. Data collection for the
Vanguard Study began in January 2009.
The design was changed in 2010 from
a door-to-door household recruitment
model to include an Alternate
Recruitment Study (ARS). The ARS
tested three different recruitment
strategies that differed as to initial point
of contact with potential participants—
direct outreach, household-based
through an NCS contractor, and
provider-based through a licensed
health care practitioner. Currently the
NCS is testing, through Provider-Based
Sampling Substudy, a further
refinement of the provider-based
sampling and recruitment using
hospitals and birthing centers in
addition to clinics and health care
provider offices that are sampled.
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
11661
Between the summer of 2011 and the
fall of 2012, the NCS held a series of
meetings with federal and non-federal
statistical sampling experts and others
to discuss the most effective sampling
approach and design for the Main
Study. The NCS had multiple separate
discussions and consultations with
additional individuals and
organizations. Based on these extensive
discussions and consultations, the NCS
is proposing the use of a multi-stage
probability sample for the Main Study.
The NCS plans to enroll women through
multiple entry points into the Main
Study, such as perinatally at hospitals
and birthing centers, and prenatally
through prenatal care providers.
Additionally, women whose children
are already enrolled will be followed as
a preconception sample of subsequent
births. Lastly, about 10% of the total
number of participants to be recruited
would be set aside for recruitment of a
convenience sample for populations
with characteristics or exposures of
particular scientific interest that would
likely be underrepresented in the other
strata.
The questions solicited in this RFI
focus on how much the NCS should
emphasize prenatal data collection, and
what the NCS could anticipate gaining
through the prospective data collection
compared to retroactive data acquisition
and the use of extant sources such as
medical records, other databases and
modeling. The issue is not whether to
have a prenatal stratum, but what
proportion of NCS resources should be
devoted to the effort.
Responses to this RFI will be used to
inform the Main Study design.
Proposed Main Study Design
1. Goals and Outcomes
The primary objective of the NCS is
to examine relationships among
exposures and outcomes that affect
children’s health and development.
These factors include environmental
exposures (with a broad definition of
environment) and biological/genetic
context. The NCS is not a study in a
conventional sense. It will primarily
function as a high quality data
collection platform for researchers to
explore hypotheses, access
biospecimens and environmental
samples, and analyze data. The Study’s
objectives stated in the Children’s
Health Act of 2000 are presented, along
with the respective design
considerations, in Table 1.
E:\FR\FM\19FEN1.SGM
19FEN1
]]>Agencies
[Federal Register Volume 78, Number 33 (Tuesday, February 19, 2013)]
[Notices]
[Pages 11660-11661]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-03643]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Clinical Center; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
[[Page 11661]]
hereby given of a meeting of the Board of Scientific Counselors of the
NIH Clinical Center.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the CLINICAL
CENTER, including consideration of personnel qualifications and
performance, and the competence of individual investigators, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Board of Scientific Counselors of the NIH
Clinical Center.
Date: March 4-5, 2013.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate the Department of Laboratory
Medicine.
Place: National Institutes of Health, Building 10, 10 Center
Drive, Room 4-2551, Bethesda, MD 20892.
Contact Person: David K. Henderson, MD, Deputy Director for
Clinical Care, Office of the Director, Clinical Center, National
Institutes of Health, Building 10, Room 6-1480, Bethesda, MD 20892,
(301) 496-3515.
Dated: February 12, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-03643 Filed 2-15-13; 8:45 am]
BILLING CODE 4140-01-P
